Magnetic field-controlled movable bio-scaffold and constructing method thereof

Patent metadata

Field	Value
Publication number	US-9402903-B2
Application number	US-201313998534-A
Country	US
Kind code	B2
Filing date	Nov 7, 2013
Priority date	Apr 8, 2013
Publication date	Aug 2, 2016
Grant date	Aug 2, 2016

Abstract

Disclosed are a magnetic field-controlled movable bio-scaffold and a method for constructing the same. The bio-scaffold is highly biocompatible and can readily move to a target site under the control of an external magnetic field.

First claim

What is claimed is:

1. A drug carrier, comprising:
a drug; and
a magnetic field-controlled movable bio-scaffold loaded with the drug, wherein the bio-scaffold has a magnetic layer coating the bio-scaffold, wherein the entire bio-scaffold is coated by the magnetic layer, wherein the magnetic field-controlled movable bio-scaffold is porous, wherein the magnetic layer coated bio-scaffold remains porous.

2. The drug carrier of claim 1 , further comprising a biocompatible metal layer formed on the magnetic layer.

3. The drug carrier of claim 1 , wherein the porous bio-scaffold structure has a three-dimensional structure composed of a photocurable polymer, wherein the drug is contained within the bio-scaffold.

4. The drug carrier of claim 3 , wherein the porous bio-scaffold structure is a cylinder, a hexahedron, an ellipsoid, a polyhedron, or a circular cone.

5. The drug carrier of claim 4 , wherein the porous bio-scaffold structure has a circular, rectangular, triangular, or penta- or higher polyhedral section on any one of XY, YZ and XZ coordinate planes in Cartesian coordinates, the sections of XY, YZ and XZ planes being the same or different.

6. The drug carrier of claim 1 , wherein the drug is the one selected from vasodilators, anti-inflammatory agents, luteinizing hormone, antidiabetics, angiogenesis inhibitors, gene silencers, AIDS vaccines, influenza vaccines, and a combination thereof.

7. The drug carrier of claim 1 , wherein the magnetic layer has the one selected from nickel (Ni), iron (Fe), cobalt (Co), neodymium (Nd), and a combination thereof.

8. The drug carrier of claim 2 , wherein the biocompatible metal layer has the one titanium (Ti), medical stainless steel, alumina (Al2O3), gold (Au), and a combination thereof.

9. The drug carrier of claim 1 , wherein the bio-scaffold has a width from 1 μm to 1,000 μm and a height from 1 μm to 1,000 μm.

10. The drug carrier of claim 1 , wherein the magnetic layer has a thickness from 50 nm to 200 nm.

11. The drug carrier of claim 2 , wherein the metal layer has a thickness from 10 nm to 50 nm.

12. The drug carrier of claim 1 , wherein the bio-scaffold has a mean pore size from 5 μm to 30 μm.

13. The drug carrier of claim 1 , wherein the porous bio-scaffold structure is a hexahedron, an ellipsoid, or a polyhedron.

14. The drug carrier of claim 1 , wherein the magnetic layer has the one selected from nickel (Ni), cobalt (Co), neodymium (Nd), and a combination thereof.

Assignees

• Daegu Gyeongbuk Inst Science & Tech

Inventors

• Choi Hong Soo
• Kim Sang Won

Classifications

• A61K41/00 Primary

  Medicinal preparations obtained by treating materials with wave energy or particle radiation {; Therapies using these preparations} · CPC title

• A61L27/30

  Inorganic materials · CPC title

• A61L27/28

  Materials for coating prostheses · CPC title

• A61L27/56 Primary

  Porous materials, {e.g. foams or sponges} · CPC title